A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare® System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease
Paul Karpecki,1 David Wirta,2 Smajo Osmanovic,3 Kavita Dhamdhere4 1Kentucky Eye Institute, Lexington, KY, USA; 2Eye Research Foundation, Newport Beach, CA, USA; 3Arlington Eye Physicians Llc, Arlington Heights, IL, USA; 4Sight Sciences, Inc., Menlo Park, CA, USACorrespondence: Kavita Dhamdhere 4040...
Guardado en:
Autores principales: | Karpecki P, Wirta D, Osmanovic S, Dhamdhere K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e43e8a01f8ba43cd8f5c212033783c68 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TearCare® system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare® treatment on subjects with dry eye disease
por: Badawi D
Publicado: (2019) -
Meibomian Gland Dysfunction: A Dermatological Perspective on Pathogenesis and Treatment Outlook
por: Gupta PK, et al.
Publicado: (2021) -
A novel system, TearCare®, for the treatment of the signs and symptoms of dry eye disease
por: Badawi D
Publicado: (2018) -
Improved Dry Eye Symptoms and Signs of Patients With Meibomian Gland Dysfunction by a Dietary Supplement
por: Kangcheng Liu, et al.
Publicado: (2021) -
DEBS – a unification theory for dry eye and blepharitis
por: Rynerson JM, et al.
Publicado: (2016)